Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Clinical Data
  • Cancer vaccine win restores Wall Street’s faith in Moderna
  • Clinical Data

Cancer vaccine win restores Wall Street’s faith in Moderna

BioPharma Dive

Moderna gained $45 billion in market value in a single day, a surge that brought the company s stock to levels not seen since 2024 and saddled it with expectations that may be tough to meet.

Oncology

Read full story

pharminent August 20, 2026 (Last updated: August 21, 2026)

BioPharma Dive

Moderna gained $45 billion in market value in a single day, a surge that brought the company s stock to levels not seen since 2024 and saddled it with expectations that may be tough to meet.

Oncology

Read full story

Post navigation

Previous: Ultragenyx, after setbacks, nabs first gene therapy approval
Next: Regeneron’s Pasatru Wins Full FDA Approval for Ultra-Rare ‘Stone Man Disease’

Related Stories

  • Clinical Data

Novartis hit as Lp(a) drug fails cardio outcomes trial

pharminent September 7, 2026
  • Clinical Data

Major trial of Roche Alzheimer’s drug kicks off in Europe

pharminent September 7, 2026
  • Clinical Data

AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study

pharminent September 4, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.